查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1612620

血液筛检市场：按产品和服务、技术、最终用户分类 - 全球预测 2025-2030

Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血液筛检市场规模预估为49亿美元，预估2024年将达53.1亿美元，复合年增长率为8.74%，到2030年将达88.2亿美元。

血液筛检是一个重要的诊断过程，旨在透过检测感染疾病、病原体和其他异常情况来确保血液安全。这个过程对于捐血和医疗诊断至关重要，旨在预防输血传播的感染疾病，并有助于早期发现爱滋病毒、肝炎和梅毒等疾病。血液筛检具有广泛的最终用途，包括医院、血库和诊断实验室，为疾病监测和公共卫生保护提供了显着的好处。全球健康和安全意识的提高以及对疾病早期检测的需求不断增加是关键的成长动力。次世代定序和分子诊断等技术的进步为市场扩张提供了有希望的可能性。自动化和人工智慧创新提供了提高筛检准确性和效率并解决错误率和处理时间等挑战的机会。然而，市场面临一些限制，例如与先进筛检技术相关的高成本以及减缓创新的严格监管环境。低收入和中等收入国家的最终用户经常与昂贵的筛检方法作斗争，凸显了持续存在的挑战。此外，病原体突变率的复杂性需要持续的研究和开发以维持筛检的有效性。为了利用新的商机，公司应该投资于具有成本效益的快速测试，并考虑与高科技公司合作以推进人工智慧驱动的诊断。研究可以同时检测多种病原体的多重测试有可能彻底改变筛检效率和安全性。对血液筛检重要性的持续教育以及政府透过优惠政策提供的支持可能会进一步推动市场成长。结合这些策略的积极主动的方法将有助于克服当前的市场障碍，推动血液筛检市场的业务显着增长，同时满足对全面健康和安全解决方案不断增长的需求。

主要市场统计
基准年[2023] 49亿美元
预测年份 [2024] 53.1亿美元
预测年份 [2030] 88.2亿美元
复合年增长率（%） 8.74%

市场动态：快速发展的血液筛检市场的关键市场洞察

供需的动态交互作用正在改变血液筛检市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 捐血需求增加，捐血人数增加
    • 感染疾病的流行和新病原体的出现
    • 降低价格并更多地采用核酸检测进行血液筛检
  • 市场限制因素
    • 血液筛检诊断药物价格上涨
  • 市场机会
    • 血液筛检设备的技术进步
    • 改进血液筛检的 POC 诊断方法
  • 市场挑战
    • 缺乏有关血液筛检的立法和政策

波特五力：驾驭血液筛检市场的策略工具

波特的五力架构是了解血液筛检市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解血液筛检市场的外部影响

外部宏观环境因素在塑造血液筛检市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解血液筛检市场的竞争格局

血液筛检市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵血液筛检市场供应商的绩效评估

FPNV定位矩阵是评估血液筛检市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了血液筛检市场的成功之路

血液筛检市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 捐血需求和捐血次数增加
      • 感染疾病的传播和新病原体的出现
      • 提高血液筛检核酸检测的可负担性和采用率
    • 抑制因素
      • 血液筛检诊断费用高
    • 机会
      • 血液筛检设备的技术进步
      • 改善血液筛检POC 诊断
    • 任务
      • 缺乏血液筛检的法律、法规和政策
  • 市场区隔分析
    • 产品：更多采用设备和耗材来执行准确的测试
    • 技术：酵素免疫分析法和质谱分析的发展
    • 用途：它在检测感染疾病和癌症方面具有重要用途，并可防止感染传播。
    • 最终用户：医院和实验室更多地使用血液筛检
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章血液筛检市场：依产品及服务分类

  • 装置
  • 完成购买
  • 试剂和套件
    • ELISA 试剂和套件
      • 共轭形式
      • 控制
      • 免疫吸附剂
      • 样品稀释液和清洗液
      • 基材
    • NAT 试剂和套件
      • 缓衝液、核苷酸、溶液
      • 酶和聚合酵素
      • 标记和检测试剂
      • 探针和引子
      • 标准与管理

第七章血液筛检市场：依技术分类

  • 酵素连结免疫吸附试验
    • 化学冷光免疫检测
    • 比色免疫检测
    • 萤光免疫分析法
  • NAT
    • 即时聚合酵素链锁反应
    • 转录介导的扩增
  • 下一代种子
  • 快速测试
  • 西方墨点法分析

第八章血液筛检市场：依最终用户分类

  • 血库
  • 医院

第九章美洲血液筛检市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太血液筛检市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的血液筛检市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Harbinger Health 筹集了 1.4 亿美元用于血液癌症筛检测试的研究
    • Oxford Biodynamics 宣布在美国开始为有摄护腺癌风险的男性提供 Episwitch 摄护腺筛检血液测试，准确率达 94%
    • 沃尔格林和 FreeNome 促进癌症血液检测试验
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Alfa Scientific Designs, Inc.
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMerieux SA
  • Danaher Corporation
  • DiaSorin SpA
  • Environmental & Scientific Instruments Co.
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies, Inc.
  • GFE
  • Grifols, SA
  • Immucor, Inc.
  • Laboratory Corporation of America Holdings
  • Lifeloc Technologies, Inc
  • Omega Laboratories, Inc.
  • OraSure Technologies, Inc.
  • Ortho Clinical Diagnostics, Inc.
  • PerkinElmer, Inc.
  • PixCell Medical Technologies Ltd.
  • Premier Biotech, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc
Product Code: MRR-374DB5A06BE3

The Blood Screening Market was valued at USD 4.90 billion in 2023, expected to reach USD 5.31 billion in 2024, and is projected to grow at a CAGR of 8.74%, to USD 8.82 billion by 2030.

Blood screening is a critical diagnostic process designed to ensure blood safety by detecting infectious diseases, pathogens, and other irregularities. This process is essential for both blood donations and medical diagnostics, aiming to prevent transfusion-transmitted infections and contribute to early detection of diseases such as HIV, hepatitis, and syphilis. Applications of blood screening span across diverse end-use settings including hospitals, blood banks, and diagnostic laboratories, offering significant benefits in terms of disease surveillance and public health protection. Enhanced global awareness on health and safety, coupled with growing demand for early disease detection, are major growth drivers. Advances in technology, like next-gen sequencing and molecular diagnostics, offer promising potential for market expansion. Innovations in automation and AI present opportunities to enhance screening accuracy and efficiency, addressing challenges like error rates and process time. However, the market faces limitations such as high costs associated with advanced screening technologies and stringent regulatory landscapes that can slow down innovation. End-users in low-to-middle income countries often struggle with cost-prohibitive screening methods, highlighting an ongoing challenge. Additionally, the complexity of pathogen mutation rates necessitates ongoing research and development to maintain screening efficacy. To capitalize on emerging opportunities, companies should invest in cost-effective, rapid testing methods, potentially through partnerships with tech firms to advance AI-driven diagnostics. Research into multiplex testing, enabling simultaneous detection of multiple pathogens, could revolutionize screening efficiency and safety. Continuous education on the importance of blood screening and government support through favorable policies could further catalyze market growth. A proactive approach combining these strategies could help overcome current market obstacles while aligning with the increasing demand for comprehensive health safety solutions, thus facilitating significant business growth in the blood screening market.

KEY MARKET STATISTICS
Base Year [2023] USD 4.90 billion
Estimated Year [2024] USD 5.31 billion
Forecast Year [2030] USD 8.82 billion
CAGR (%) 8.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Screening Market

The Blood Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for donated blood and rising number of blood donations
    • Rising prevalence of infectious diseases and the emergence of newer pathogens
    • Increase in affordability and adoption of nucleic acid test for blood screening
  • Market Restraints
    • High price for blood screening diagnostics
  • Market Opportunities
    • Technological Advancements in blood screening devices
    • Improved POC diagnostics for blood screening
  • Market Challenges
    • Lack of legislation, regulations, and policies on blood screening

Porter's Five Forces: A Strategic Tool for Navigating the Blood Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Screening Market

A detailed market share analysis in the Blood Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Screening Market

A strategic analysis of the Blood Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alfa Scientific Designs, Inc., Becton, Dickinson And Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux SA, Danaher Corporation, DiaSorin S.p.A., Environmental & Scientific Instruments Co., F. Hoffmann-La Roche AG, GE HealthCare Technologies, Inc., GFE, Grifols, S.A., Immucor, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc, Omega Laboratories, Inc., OraSure Technologies, Inc., Ortho Clinical Diagnostics, Inc., PerkinElmer, Inc., PixCell Medical Technologies Ltd., Premier Biotech, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech Plc.

Market Segmentation & Coverage

This research report categorizes the Blood Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Instruments, Outright Purchase, and Reagents & Kits. The Reagents & Kits is further studied across ELISA Reagents & Kits and NAT Reagents & Kits. The ELISA Reagents & Kits is further studied across Conjugates, Controls, Immunosorbents, Sample Diluents & Wash Solutions, and Substrates. The NAT Reagents & Kits is further studied across Buffers, Nucleotides, & Solutions, Enzymes & Polymerases, Labeling & Detection Reagents, Probes & Primers, and Standards & Controls.
  • Based on Technology, market is studied across ELISA, NAT, NGS, Rapid Tests, and Western Blot Assays. The ELISA is further studied across Chemiluminescent Immunoassay, Colorimetric Immunoassay, and Fluorescent immunoassay. The NAT is further studied across Real-Time Polymerase Chain Reaction and Transcription-Mediated Amplification.
  • Based on End-User, market is studied across Blood Banks and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for donated blood and rising number of blood donations
      • 5.1.1.2. Rising prevalence of infectious diseases and the emergence of newer pathogens
      • 5.1.1.3. Increase in affordability and adoption of nucleic acid test for blood screening
    • 5.1.2. Restraints
      • 5.1.2.1. High price for blood screening diagnostics
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in blood screening devices
      • 5.1.3.2. Improved POC diagnostics for blood screening
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of legislation, regulations, and policies on blood screening
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising adoption of instruments and consumables for conducting accurate tests
    • 5.2.2. Technology: Development of enzyme-linked immunosorbent assay and mass spectrometry technology
    • 5.2.3. Application: Significant applications of infectious disease and cancer screening to prevent the spread of infections
    • 5.2.4. End-User: Increasing use of blood screening in hospitals and laboratories
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Screening Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Outright Purchase
  • 6.4. Reagents & Kits
    • 6.4.1. ELISA Reagents & Kits
      • 6.4.1.1. Conjugates
      • 6.4.1.2. Controls
      • 6.4.1.3. Immunosorbents
      • 6.4.1.4. Sample Diluents & Wash Solutions
      • 6.4.1.5. Substrates
    • 6.4.2. NAT Reagents & Kits
      • 6.4.2.1. Buffers, Nucleotides, & Solutions
      • 6.4.2.2. Enzymes & Polymerases
      • 6.4.2.3. Labeling & Detection Reagents
      • 6.4.2.4. Probes & Primers
      • 6.4.2.5. Standards & Controls

7. Blood Screening Market, by Technology

  • 7.1. Introduction
  • 7.2. ELISA
    • 7.2.1. Chemiluminescent Immunoassay
    • 7.2.2. Colorimetric Immunoassay
    • 7.2.3. Fluorescent immunoassay
  • 7.3. NAT
    • 7.3.1. Real-Time Polymerase Chain Reaction
    • 7.3.2. Transcription-Mediated Amplification
  • 7.4. NGS
  • 7.5. Rapid Tests
  • 7.6. Western Blot Assays

8. Blood Screening Market, by End-User

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Hospitals

9. Americas Blood Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Blood Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Blood Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Harbinger Health Raises $140M to Study Blood-Based Cancer Screening Test
    • 12.3.2. Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch Prostate Screening Blood Test to Men With Prostate Cancer Risk
    • 12.3.3. Walgreens and Freenome to Advance Blood-Based Test Trials For Cancer
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Alfa Scientific Designs, Inc.
  • 3. Becton, Dickinson And Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bio-Techne Corporation
  • 6. bioMerieux SA
  • 7. Danaher Corporation
  • 8. DiaSorin S.p.A.
  • 9. Environmental & Scientific Instruments Co.
  • 10. F. Hoffmann-La Roche AG
  • 11. GE HealthCare Technologies, Inc.
  • 12. GFE
  • 13. Grifols, S.A.
  • 14. Immucor, Inc.
  • 15. Laboratory Corporation of America Holdings
  • 16. Lifeloc Technologies, Inc
  • 17. Omega Laboratories, Inc.
  • 18. OraSure Technologies, Inc.
  • 19. Ortho Clinical Diagnostics, Inc.
  • 20. PerkinElmer, Inc.
  • 21. PixCell Medical Technologies Ltd.
  • 22. Premier Biotech, Inc.
  • 23. Siemens Healthineers AG
  • 24. Thermo Fisher Scientific Inc.
  • 25. Trinity Biotech Plc

LIST OF FIGURES

  • FIGURE 1. BLOOD SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD SCREENING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY OUTRIGHT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOSORBENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE DILUENTS & WASH SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD SCREENING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD SCREENING MARKET SIZE, BY BUFFERS, NUCLEOTIDES, & SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYMES & POLYMERASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD SCREENING MARKET SIZE, BY LABELING & DETECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD SCREENING MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD SCREENING MARKET SIZE, BY STANDARDS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD SCREENING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD SCREENING MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD SCREENING MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD SCREENING MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD SCREENING MARKET SIZE, BY WESTERN BLOT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 355. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 356. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 357. TURKEY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES BLOOD SCREENING MARKE